Peppe Sasso
@radiopeppe
Followers
758
Following
1K
Media
189
Statuses
2K
Radiation Oncologist | Auckland | Mediterranean Soul | Wannabe Tennis Coach | Slow-Food Cook | Independent Movies Enthusiast | Ex Radio Dj | Views are mine
Tamaki, Aotearoa
Joined March 2015
Sorry to miss a spectacular #SABR2025 but this weekend the keynote 🎶 on stage in #auckland was @LennyKravitz 🎸@DrewMoghanaki @_ShankarSiva @PBlanchardMD
0
0
5
Genomic and Transcriptomic Profiling of Radiation-Resistant, Locally Recurrent Prostate Cancer - PubMed
pubmed.ncbi.nlm.nih.gov
Overall, these results suggest that LRR-PCa has a distinct genomic and transcriptomic landscape from de novo prostate cancer. Specifically, LRR-PCa has an enrichment in SNVs in genes associated with...
0
1
4
I don’t think @JoeBiden could have found a better doctor to take care of him than @NehaVapiwala @PennMedicine. The best of the best! 👏
It was the honor of a lifetime to contribute to the care of @JoeBiden. Every cancer patient deserves respect. Every cancer patient matters. 2/2
2
4
51
Radiation oncologists are trained to deliver safe, high-precision radiotherapy as part of a #cancer care team. We follow the best available evidence & develop customized, cost-effective plans. Science guides our treatments, but humanity guides our practice. 1/2
In the News: ASTRO marks President Biden’s treatment milestone with ASTRO President Neha Vapiwala, MD leading the treatment team. @NehaVapiwala @SameerKeoleMD @PennMedicine @JoeBiden
https://t.co/9tHLn9zgQt
2
41
235
Important data 👇
#ESMO25 Highly anticipated results of ENZARAD The results speak for themselves but I think this is something @DrSpratticus has been harping about for blanket ARSI for high risk #ProstateCancer patients
0
8
24
📢#ESMO25 @Alex_Papachris presents long-term data from SAKK 01/10: 1x carboplatin (AUC7) + involved-node RT (30–36 Gy) for stage IIA/B seminoma new SOC? 👨⚕️ n=116 | FU: 8.1y 🔹 10y PFS: 92.8% 🔹 OS: 99.1% | CSS: 100% 🔹 Minimal late toxicity | No in-field 2° cancers ✅ Durable,
1
20
41
🚨Important update from ProtecT #ProstateCancer trial after central pathology review 1️⃣ Which early PCa need treatment? Which do not? 2️⃣ For “bad” early PCa, do RP or RT prevent long-term (15y) metastasis? 🧵1/ @OncoAlert @urotoday @PCF_Science @JAMAOnc @Uroweb @AmerUrological
1/2 Just published in @JAMAOnc: 15-year outcomes of Active Monitoring, Surgery, and Radiotherapy for cribriform-positive and cribriform-negative prostate cancer in the ProtecT trial. Secondary analysis based on centralised biopsy review🔬 Article:
7
77
151
1/2 Just published in @JAMAOnc: 15-year outcomes of Active Monitoring, Surgery, and Radiotherapy for cribriform-positive and cribriform-negative prostate cancer in the ProtecT trial. Secondary analysis based on centralised biopsy review🔬 Article:
jamanetwork.com
This secondary analysis of the PROTECT randomized clinical trial assesses the association between cribriform-positive and cribriform-negative prostate cancer and risk of metastasis in patients who...
2
25
64
Thanks for @MedResearchNZ for the wonderful celebration of 70 years of Auckland and Aotearoa amazing research and for the generosity of everyone donating to medical research ❤️
1
0
5
ESMO 2024 Quick Take Insights: Prostate Cancer - #ARANOTE: Darolutamide + ADT shows significant rPFS benefits in mHSPC, offering a new treatment without docetaxel. - #PEACE3Study: Radium-223 + enzalutamide in mCRPC enhances rPFS & OS when used with bone protection in patients
1
17
50
@rweichselbaum @MDAndersonNews GU005 allowed hotspots of 38.7 Gy. PACE-B allowed hotspots of 48-50 Gy. So there is a 13 Gy eqd2 difference even between prescription doses and even more when accounting for hotspots. Thus GU005 had a bit more BCR but lower tox. PACE-B had a little better BCR and more tox.
4
9
26
Read now this fantastic article from Manila Bulletin "Finding hope in precision. More hope for patients with brain tumor using CyberKnife" and learn more on the benefits of the #CyberKnife System for the patients. https://t.co/of35DEanQ9
#AccurayExpandRT
mb.com.ph
By Dr. Jaymee Fernandez-RamosRadiation oncologist, Asian Cancer InstituteAsian Hospital and Medical CenterA diagnosis of a brain tumor is sure to send anyone to...
0
3
7
Congrats to @_ShankarSiva on presenting new pooled analysis from the FASTRACK & FASTRACK II trials at #ASTRO25. The data support the use of ultra-hypofractionated SABR schedules for renal cell carcinoma. Read about TROG 15.03/ANZUP 16001 – FASTRACK II : https://t.co/w7fPoHjXuW
0
6
19
Huge thanks to @SethBla and his team at @Accuray for organising the SABR symposium. It was great to meet again @SbrtSean @_ShankarSiva and make acquaintance with stellar experts @JimmGrimm1 @KristinRedmond2. Arrivederci 😊
0
1
3
Back from #ASTRO2025 in San Francisco. @FlyAirNZ landed on time, friendly customs and quarantine, on a Uber to clinic in <15 mins. I❤️NZ
1
0
2
#WRAD may have passed, but the momentum continues! Let's keep celebrating the power of radiotherapy. 📅 Sept. 29th 3:30 PM 📍 Booth 525 #ASTRO25 🎤 Lucinda Morris, M.D. “One Voice for Radiotherapy: Celebrating the First World Radiotherapy Awareness Day” 🔗 https://t.co/eFQesStmAl
0
1
4